Materiały źródłowe

• #1 Arteriovenous malformations: epidemiology and clinical presentation – PubMed

  https://pubmed.ncbi.nlm.nih.gov/22107853/

  Arteriovenous malformations (AVMs) of the brain are relatively rare congenital developmental vascular lesions. […] The incidence of asymptomatic AVMs is increasing due to widespread availability of noninvasive imaging methods. […] Since the most severe complication of an AVM is hemorrhagic stroke, most epidemiologic studies have concentrated on the hemorrhage risk and its risk factors. […] In this article, the authors discuss the epidemiology, presenting symptoms, and hemorrhage risk associated with brain AVMs.

• #2 Arteriovenous Malformations: Practice Essentials, Background, Pathophysiology

  https://emedicine.medscape.com/article/1160167-overview

  In population-based studies, 38-70% of brain AVMs present initially with hemorrhages. The overall risk of intracranial hemorrhage in patients with known AVM is 24% per year. […] Despite the presumed congenital origin of AVMs, the clinical presentation most commonly occurs in young adults. […] A history of subtle learning disorder is elicited in 66% of adults with AVMs. This suggests early effects that are largely subclinical and do not come to medical attention.

• #3

  https://journals.lww.com/neurosurgery/fulltext/2000/08000/the_epidemiology_of_brain_arteriovenous.23.aspx

  Common estimates of the prevalence rate for pial arteriovenous malformations (AVMs) of the brain vary widely, and their accuracy is questionable. Our objective was to critically review the original sources from which these rates were derived and to establish best estimates for both the incidence and prevalence of the disease. […] Many of the prevalence estimates (500600/100,000 population) were based on autopsy data, a source that is inherently biased. Other estimates (140/100,000 population) originated from an inappropriate analysis of data from the Cooperative Study. The most reliable information comes from a population-based study of Olmsted County, MN, but prevalence data specific to AVMs was not found in that study. […] The estimates for AVM prevalence that are published in the medical literature are unfounded. Because of the rarity of the disease and the existence of asymptomatic patients, establishing a true prevalence rate is not feasible. Owing to variation in the detection rate of asymptomatic AVMs, the most reliable estimate for the occurrence of the disease is the detection rate for symptomatic lesions: 0.94 per 100,000 person-years (95% confidence interval, 0.571.30/100,000 person-years). This figure is derived from a single population-based study, but it is supported by a reanalysis of other data sources. The prevalence of detected, active (at risk) AVM disease is unknown, but it can be inferred from incidence data to be lower than 10.3 per 100,000 population.

• #4 Arteriovenous Malformations: Practice Essentials, Background, Pathophysiology

  https://emedicine.medscape.com/article/1160167-overview

  The detection rate in the general population based on prospective data from the New York Islands AVM Study is approximately 1.34 per 100,000 person-years. […] The prevalence of cerebral arteriovenous malformations (AVMs) in the United States is not known. Given the low threshold for MRI neuroimaging, many patients’ conditions are now discovered before they experience a brain hemorrhage. […] Reported detection rates range between 0.89 and 1.24 per 100,000 person-years according to reports from Australia, Sweden, and Scotland. The prevalence of cerebral AVMs in Scotland has been estimated to be 18 per 100,000 person-years. […] Although 300,000 persons in the United States may harbor AVMs, only 12% of AVMs are estimated to become symptomatic. Death occurs in 10-15% of patients who have hemorrhage, and morbidity of various degrees occurs in approximately 30-50%.

• #5 Arteriovenous Malformations: Practice Essentials, Background, Pathophysiology

  https://emedicine.medscape.com/article/1160167-overview

  The detection rate in the general population based on prospective data from the New York Islands AVM Study is approximately 1.34 per 100,000 person-years. […] The prevalence of cerebral arteriovenous malformations (AVMs) in the United States is not known. Given the low threshold for MRI neuroimaging, many patients’ conditions are now discovered before they experience a brain hemorrhage. […] Reported detection rates range between 0.89 and 1.24 per 100,000 person-years according to reports from Australia, Sweden, and Scotland. The prevalence of cerebral AVMs in Scotland has been estimated to be 18 per 100,000 person-years. […] Although 300,000 persons in the United States may harbor AVMs, only 12% of AVMs are estimated to become symptomatic. Death occurs in 10-15% of patients who have hemorrhage, and morbidity of various degrees occurs in approximately 30-50%.

• #6 The epidemiology of brain arteriovenous malformations in adults

  https://era.ed.ac.uk/handle/1842/793

  In SIVMS, the crude incidence of brain AVMs in Scotland in 1999 and 2000 was 1.1 (95%CI 0.9 to 1.4) per 100,000 adults per year. […] There appeared to be significant differences between SIVMS and well-established hospital-based cohorts. Having established brain AVM prevalence, incidence and the characteristics of presenting adults, the next stage for this work is to describe prognosis for this enlarging population-based cohort.

• #7 Epidemiology and natural history of arteriovenous malformations in: Neurosurgical Focus Volume 11 Issue 5 (2001) Journals

  https://thejns.org/focus/view/journals/neurosurg-focus/11/5/foc.2001.11.5.2.xml

  The epidemiology and natural history of cerebral arteriovenous malformations (AVMs) remains incompletely elucidated. Several factors are responsible. With regard to the incidence and prevalence of AVMs, the results of prior studies have suffered because of the retrospective design, the use of nonspecific ICD-9 codes, and a focus on small genetically isolated populations. Recent data from the New York Islands AVM Hemorrhage Study, an ongoing, prospective, population-based survey determining the incidence of AVM-related hemorrhage and the associated rates of morbidity and mortality in a zip codedefined population of 10 million people, suggests that the AVM detection rate is 1.21/100,000 person-years (95% confidence interval [CI] 1.021.42) and the incidence of AVM-hemorrhage is 0.42/100,000 person-years (95% CI 0.320.55).

• #8 A nationwide cohort study on incidence and mortality associated with extracranial vascular malformations | Scientific Reports

  https://www.nature.com/articles/s41598-023-41278-z

  Extracranial vascular malformations are abnormal formations of blood vessels located outside the brain (extracranial) that develop during fetal development. […] There are very few studies have investigated the nationwide incidence and quantitative mortality of vascular malformations in terms of their subtypes. […] This nationwide population-based study evaluated 70,517 patients with vascular malformations from 2008 to 2021. […] The annual incidence (per 100,000 population) of overall vascular, venous, capillary, arteriovenous, and lymphatic malformations was 9.85, 1.48, 2.31, 0.24, and 5.82 cases, respectively. […] Moreover, among the vascular malformation subgroups, the adjusted hazard ratio of mortality was the highest for arteriovenous malformations. […] The overall annual incidence of vascular malformations was 9.85 cases per 100,000 population in Korea from 2008 to 2021.

• #9 A nationwide cohort study on incidence and mortality associated with extracranial vascular malformations | Scientific Reports

  https://www.nature.com/articles/s41598-023-41278-z

  In total, 70,517 patients with extracranial vascular malformations were identified during this period, with an annual incidence of 9.85 cases per 100,000 population. […] In the subgroup analysis, the annual incidences of VMs, CMs, AVMs, and LMs during the same period were 1.48, 2.31, 0.24, and 5.82 cases per 100,000 population, respectively. […] In addition, based on the Kaplan-Meier curve, patients with LMs had the lowest survival rate as the age of several patients at the diagnosis of LMs was higher than that of patients with other extracranial vascular malformations. […] Among these, it was confirmed that the HR of AVMs was the highest.

• #10

  https://journals.lww.com/neurosurgery/fulltext/2000/08000/the_epidemiology_of_brain_arteriovenous.23.aspx

  Common estimates of the prevalence rate for pial arteriovenous malformations (AVMs) of the brain vary widely, and their accuracy is questionable. Our objective was to critically review the original sources from which these rates were derived and to establish best estimates for both the incidence and prevalence of the disease. […] Many of the prevalence estimates (500600/100,000 population) were based on autopsy data, a source that is inherently biased. Other estimates (140/100,000 population) originated from an inappropriate analysis of data from the Cooperative Study. The most reliable information comes from a population-based study of Olmsted County, MN, but prevalence data specific to AVMs was not found in that study. […] The estimates for AVM prevalence that are published in the medical literature are unfounded. Because of the rarity of the disease and the existence of asymptomatic patients, establishing a true prevalence rate is not feasible. Owing to variation in the detection rate of asymptomatic AVMs, the most reliable estimate for the occurrence of the disease is the detection rate for symptomatic lesions: 0.94 per 100,000 person-years (95% confidence interval, 0.571.30/100,000 person-years). This figure is derived from a single population-based study, but it is supported by a reanalysis of other data sources. The prevalence of detected, active (at risk) AVM disease is unknown, but it can be inferred from incidence data to be lower than 10.3 per 100,000 population.

• #11 Arteriovenous Malformations: Practice Essentials, Background, Pathophysiology

  https://emedicine.medscape.com/article/1160167-overview

  The detection rate in the general population based on prospective data from the New York Islands AVM Study is approximately 1.34 per 100,000 person-years. […] The prevalence of cerebral arteriovenous malformations (AVMs) in the United States is not known. Given the low threshold for MRI neuroimaging, many patients’ conditions are now discovered before they experience a brain hemorrhage. […] Reported detection rates range between 0.89 and 1.24 per 100,000 person-years according to reports from Australia, Sweden, and Scotland. The prevalence of cerebral AVMs in Scotland has been estimated to be 18 per 100,000 person-years. […] Although 300,000 persons in the United States may harbor AVMs, only 12% of AVMs are estimated to become symptomatic. Death occurs in 10-15% of patients who have hemorrhage, and morbidity of various degrees occurs in approximately 30-50%.

• #12 Brain arteriovenous malformation | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/brain-arteriovenous-malformation?lang=us

  Brain arteriovenous malformations are thought to occur in approximately 0.05% of the population. There is no gender predilection. […] Although arteriovenous malformations are thought to represent a congenital abnormality, they are rarely found incidentally in the very young and many de novo lesions have been described amongst adults. They are thought to expand over time. Despite this, a third of arteriovenous malformations that are diagnosed due to hemorrhage are identified before the age of 20 years. Overall, they are diagnosed at a mean age of 31 years.

• #13

  https://journals.lww.com/jova/fulltext/2023/09000/estimate_of_the_prevalence_of_vascular.3.aspx

  To estimate the prevalence of vascular malformations using retrospective data collected from 1999 to 2020 in a specialty vascular anomalies service. […] A total of 1501 patients were identified, including 1233 with slow-flow malformations and 147 with arteriovenous malformations. […] The prevalence of extracranial arteriovenous malformation is estimated to be around one case per 10,000 population. […] An updated estimate, more accurate than those previously published, of the prevalence of vascular malformations has been obtained. […] A recent study based on hospital registry data in Denmark has estimated a prevalence of 0.4 cases per 100,000 for arteriovenous malformation (AVM) and an implied prevalence of 5 per 100,000 for slow-flow malformations. […] In the absence of a more accurate figure, an estimate of the prevalence of AVM is calculated in proportion to the prevalence of slow-flow malformations as described in the methods. AVM is estimated to be around 12% of the prevalence of slow-flow malformations overall (Table 1), or approximately 1 case per 10,000 population. […] The prevalence of AVMs has been more difficult to estimate but appears to be around 1 in every 10,000. […] We have provided an estimated prevalence of 1 case per 1,000 births for slow-flow malformations and 1 case per 10,000 births for extracranial arteriovenous malformations.

• #14 Epidemiology of Cerebral Arteriovenous Malformations in Children – ISPN Guide

  https://ispn.guide/vascular-disorders-of-the-nervous-system-in-children/cerebral-arteriovenous-malformations-in-children-homepage-2025/epidemiology-of-cerebral-arteriovenous-malformations-in-children/

  0.89 to 1.34 per 100,000 person-years: Incidence rate estimates range from 0.89 to 1.34 cases per 100,000 person-years (3,4,32,33). […] 5.47 to 18 per 100,000: Prevalence estimates range from 5.47 to 18 cases per 100,000 people (4,5,6). […] 0.02% prevalence in children: The pediatric age group comprises 12% to 18% of all AVMs from major centers, and the overall prevalence in children is about 0.02% of the pediatric population (34,35,36,37). […] An estimated 18% to 20% of patients with symptomatic AVMs present prior to age 15 years (38). […] There is no sex predilection for pediatric cerebral AVMs (40). […] There are no data supporting any variance in incidence as a function of geographic location. […] The understanding of genetic risk factors is evolving but seems related primarily to dysfunction in the regulation of genes linked to inflammation, angiogenesis, vasculogenesis, cell migration, and the cytoskeletal system (41).

• #15 Cerebral Arteriovenous Malformation AVM

  https://www.rch.org.au/kidsinfo/fact_sheets/Cerebral_Arteriovenous_Malformation_AVM/

  AVMs in the brain occur in approximately 1 in 3,300 people and bleeding from an AVM most often occurs between 10 and 30 years of age. […] Your child will have regular surveillance imaging and follow-up appointments with their treating team. […] Yes it is possible that after treatment for a cerebral AVM there may be recurrence of a tiny cluster of AVM vessels in the area treated. This is why your treating team of doctors will arrange follow up imaging (with MRI or angiogram) for several years after the initial treatment to check for this possibility.

• #16 Brain arteriovenous malformation | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/brain-arteriovenous-malformation?lang=us

  Brain arteriovenous malformations are thought to occur in approximately 0.05% of the population. There is no gender predilection. […] Although arteriovenous malformations are thought to represent a congenital abnormality, they are rarely found incidentally in the very young and many de novo lesions have been described amongst adults. They are thought to expand over time. Despite this, a third of arteriovenous malformations that are diagnosed due to hemorrhage are identified before the age of 20 years. Overall, they are diagnosed at a mean age of 31 years.

• #17 Epidemiology of Arteriovenous Malformations | East Bay Brain & Spine

  https://www.eastbaybrainandspine.com/conditions/vascular/arteriovenous-malformations/epidemiology-arteriovenous-malformations/

  Arteriovenous malformations (AVMs) are relatively rare and occur in less than 1% of the general population. […] The incidence of detection is estimated to be around 1 in every 100,000 people per year. The overall prevalence is believed to be around 18 per 100,000 individuals. […] AVMs can be found at any age, but symptoms usually first appear between the ages of 10 and 40. […] Both sexes are equally affected by AVMs. However, hemorrhage due to AVM rupture is reportedly more common in females. […] The annual risk of hemorrhage in patients with untreated AVMs is estimated to be around 2-4% per year. […] The mortality rate after an AVM rupture is estimated to be around 10-15%, and morbidity (disability) rates are much higher. […] The epidemiology of AVMs underscores the importance of their early detection and appropriate management.

• #18 Brain arteriovenous malformation | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/brain-arteriovenous-malformation?lang=us

  Brain arteriovenous malformations are thought to occur in approximately 0.05% of the population. There is no gender predilection. […] Although arteriovenous malformations are thought to represent a congenital abnormality, they are rarely found incidentally in the very young and many de novo lesions have been described amongst adults. They are thought to expand over time. Despite this, a third of arteriovenous malformations that are diagnosed due to hemorrhage are identified before the age of 20 years. Overall, they are diagnosed at a mean age of 31 years.

• #19 Brain arteriovenous malformation | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/brain-arteriovenous-malformation?lang=us

  Brain arteriovenous malformations are thought to occur in approximately 0.05% of the population. There is no gender predilection. […] Although arteriovenous malformations are thought to represent a congenital abnormality, they are rarely found incidentally in the very young and many de novo lesions have been described amongst adults. They are thought to expand over time. Despite this, a third of arteriovenous malformations that are diagnosed due to hemorrhage are identified before the age of 20 years. Overall, they are diagnosed at a mean age of 31 years.

• #20 Spinal arteriovenous malformations

  http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-50442021000200077

  sAVMs make up the most common vascular anomaly of the spine, with an estimated proportion of 60-80%. sAVMs account for 3-4% of all intradural spinal cord mass lesions, and dural sAVMs are the most common vascular malformation, accounting for 50-85% of all lesions. […] Lad et al. analyzed National Inpatient Sample data from 1995 to 2006, screening admissions with a primary diagnostic code for spinal vascular malformation. In these 11 years, 3291 patients were admitted with a diagnosis of spinal vascular malformation, with an average of 299 annual admissions with a new diagnosis of sAVM; the majority of admissions corresponded to male patients (57%) in the 45-64-year age range (36% of admissions). […] Jellema et al. analyzed all reported series with more than five patients affected by direct sAVMs, detecting there were 968 men against 210 women (ratio almost 5:1). The mean age at the time of diagnosis was found to be 55-60 years; patients under the age of 30 were rarely reported (14 patients under age 30 were found in the 1178 patients or 1%). The youngest patients reported were 22 years at the time of diagnosis. In their study was concluded that no patient under the age of 20 has ever been reported.

• #21 Brain arteriovenous malformation | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/brain-arteriovenous-malformation?lang=us

  Brain arteriovenous malformations are thought to occur in approximately 0.05% of the population. There is no gender predilection. […] Although arteriovenous malformations are thought to represent a congenital abnormality, they are rarely found incidentally in the very young and many de novo lesions have been described amongst adults. They are thought to expand over time. Despite this, a third of arteriovenous malformations that are diagnosed due to hemorrhage are identified before the age of 20 years. Overall, they are diagnosed at a mean age of 31 years.

• #22 Epidemiology of Arteriovenous Malformations | East Bay Brain & Spine

  https://www.eastbaybrainandspine.com/conditions/vascular/arteriovenous-malformations/epidemiology-arteriovenous-malformations/

  Arteriovenous malformations (AVMs) are relatively rare and occur in less than 1% of the general population. […] The incidence of detection is estimated to be around 1 in every 100,000 people per year. The overall prevalence is believed to be around 18 per 100,000 individuals. […] AVMs can be found at any age, but symptoms usually first appear between the ages of 10 and 40. […] Both sexes are equally affected by AVMs. However, hemorrhage due to AVM rupture is reportedly more common in females. […] The annual risk of hemorrhage in patients with untreated AVMs is estimated to be around 2-4% per year. […] The mortality rate after an AVM rupture is estimated to be around 10-15%, and morbidity (disability) rates are much higher. […] The epidemiology of AVMs underscores the importance of their early detection and appropriate management.

• #23 Epidemiology of Arteriovenous Malformations | East Bay Brain & Spine

  https://www.eastbaybrainandspine.com/conditions/vascular/arteriovenous-malformations/epidemiology-arteriovenous-malformations/

  Arteriovenous malformations (AVMs) are relatively rare and occur in less than 1% of the general population. […] The incidence of detection is estimated to be around 1 in every 100,000 people per year. The overall prevalence is believed to be around 18 per 100,000 individuals. […] AVMs can be found at any age, but symptoms usually first appear between the ages of 10 and 40. […] Both sexes are equally affected by AVMs. However, hemorrhage due to AVM rupture is reportedly more common in females. […] The annual risk of hemorrhage in patients with untreated AVMs is estimated to be around 2-4% per year. […] The mortality rate after an AVM rupture is estimated to be around 10-15%, and morbidity (disability) rates are much higher. […] The epidemiology of AVMs underscores the importance of their early detection and appropriate management.

• #24 Epidemiology of Cerebral Arteriovenous Malformations in Children – ISPN Guide

  https://ispn.guide/vascular-disorders-of-the-nervous-system-in-children/cerebral-arteriovenous-malformations-in-children-homepage-2025/epidemiology-of-cerebral-arteriovenous-malformations-in-children/

  0.89 to 1.34 per 100,000 person-years: Incidence rate estimates range from 0.89 to 1.34 cases per 100,000 person-years (3,4,32,33). […] 5.47 to 18 per 100,000: Prevalence estimates range from 5.47 to 18 cases per 100,000 people (4,5,6). […] 0.02% prevalence in children: The pediatric age group comprises 12% to 18% of all AVMs from major centers, and the overall prevalence in children is about 0.02% of the pediatric population (34,35,36,37). […] An estimated 18% to 20% of patients with symptomatic AVMs present prior to age 15 years (38). […] There is no sex predilection for pediatric cerebral AVMs (40). […] There are no data supporting any variance in incidence as a function of geographic location. […] The understanding of genetic risk factors is evolving but seems related primarily to dysfunction in the regulation of genes linked to inflammation, angiogenesis, vasculogenesis, cell migration, and the cytoskeletal system (41).

• #25 Spinal arteriovenous malformations

  http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-50442021000200077

  sAVMs make up the most common vascular anomaly of the spine, with an estimated proportion of 60-80%. sAVMs account for 3-4% of all intradural spinal cord mass lesions, and dural sAVMs are the most common vascular malformation, accounting for 50-85% of all lesions. […] Lad et al. analyzed National Inpatient Sample data from 1995 to 2006, screening admissions with a primary diagnostic code for spinal vascular malformation. In these 11 years, 3291 patients were admitted with a diagnosis of spinal vascular malformation, with an average of 299 annual admissions with a new diagnosis of sAVM; the majority of admissions corresponded to male patients (57%) in the 45-64-year age range (36% of admissions). […] Jellema et al. analyzed all reported series with more than five patients affected by direct sAVMs, detecting there were 968 men against 210 women (ratio almost 5:1). The mean age at the time of diagnosis was found to be 55-60 years; patients under the age of 30 were rarely reported (14 patients under age 30 were found in the 1178 patients or 1%). The youngest patients reported were 22 years at the time of diagnosis. In their study was concluded that no patient under the age of 20 has ever been reported.

• #26 Epidemiology of Cerebral Arteriovenous Malformations in Children – ISPN Guide

  https://ispn.guide/vascular-disorders-of-the-nervous-system-in-children/cerebral-arteriovenous-malformations-in-children-homepage-2025/epidemiology-of-cerebral-arteriovenous-malformations-in-children/

  0.89 to 1.34 per 100,000 person-years: Incidence rate estimates range from 0.89 to 1.34 cases per 100,000 person-years (3,4,32,33). […] 5.47 to 18 per 100,000: Prevalence estimates range from 5.47 to 18 cases per 100,000 people (4,5,6). […] 0.02% prevalence in children: The pediatric age group comprises 12% to 18% of all AVMs from major centers, and the overall prevalence in children is about 0.02% of the pediatric population (34,35,36,37). […] An estimated 18% to 20% of patients with symptomatic AVMs present prior to age 15 years (38). […] There is no sex predilection for pediatric cerebral AVMs (40). […] There are no data supporting any variance in incidence as a function of geographic location. […] The understanding of genetic risk factors is evolving but seems related primarily to dysfunction in the regulation of genes linked to inflammation, angiogenesis, vasculogenesis, cell migration, and the cytoskeletal system (41).

• #27 Epidemiology of ruptured brain arteriovenous malformation: a National Cohort Study in Korea in: Journal of Neurosurgery Volume 130 Issue 6 (2018) Journals

  https://thejns.org/view/journals/j-neurosurg/130/6/article-p1965.xml

  Brain arteriovenous malformation (BAVM) is a rare cerebrovascular disease that causes intracranial hemorrhage. Although several reports have demonstrated the epidemiological features of BAVM in Western countries, no epidemiological investigations regarding BAVM have been reported in Korea. The authors aimed to investigate the national epidemiology of ruptured BAVM in a Korean population. […] A total of 8,802,696 person-years of observation were noted. During observation, 308 patients were diagnosed with a ruptured BAVM. The crude incidence of ruptured BAVM was 3.5 per 100,000 person-years. […] The standardized incidence of ruptured BAVMs was 3.6 per 100,000 person-years in Korea. Ruptured BAVMs resulted in high mortality and disability rates.

• #28 Epidemiology of Cerebral Arteriovenous Malformations in Children – ISPN Guide

  https://ispn.guide/vascular-disorders-of-the-nervous-system-in-children/cerebral-arteriovenous-malformations-in-children-homepage-2025/epidemiology-of-cerebral-arteriovenous-malformations-in-children/

  0.89 to 1.34 per 100,000 person-years: Incidence rate estimates range from 0.89 to 1.34 cases per 100,000 person-years (3,4,32,33). […] 5.47 to 18 per 100,000: Prevalence estimates range from 5.47 to 18 cases per 100,000 people (4,5,6). […] 0.02% prevalence in children: The pediatric age group comprises 12% to 18% of all AVMs from major centers, and the overall prevalence in children is about 0.02% of the pediatric population (34,35,36,37). […] An estimated 18% to 20% of patients with symptomatic AVMs present prior to age 15 years (38). […] There is no sex predilection for pediatric cerebral AVMs (40). […] There are no data supporting any variance in incidence as a function of geographic location. […] The understanding of genetic risk factors is evolving but seems related primarily to dysfunction in the regulation of genes linked to inflammation, angiogenesis, vasculogenesis, cell migration, and the cytoskeletal system (41).

• #29 Epidemiology of Cerebral Arteriovenous Malformations in Children – ISPN Guide

  https://ispn.guide/vascular-disorders-of-the-nervous-system-in-children/cerebral-arteriovenous-malformations-in-children-homepage-2025/epidemiology-of-cerebral-arteriovenous-malformations-in-children/

  HHT, also known as Osler-Weber-Rendu syndrome, is the most common cause of multiple cerebral AVMs (42). A meta-analysis found the prevalence of cerebral AVMs in patients with HHT to be 10.4%, with 42.2% of HHT AVM patients having multiple AVMs (43). […] CM-AVM due to RASA1 mutations has been associated with intracranial AVMs and other vascular malformations (44). […] Klippel-Trnaunay syndrome (associated with PIK3CA mutations), Parkes Weber syndrome (often associated with RASA1 mutations), and cerebrofacial arteriovenous metameric syndrome have been associated with intracranial AVMs (41).

• #30 Epidemiology of Cerebral Arteriovenous Malformations in Children – ISPN Guide

  https://ispn.guide/vascular-disorders-of-the-nervous-system-in-children/cerebral-arteriovenous-malformations-in-children-homepage-2025/epidemiology-of-cerebral-arteriovenous-malformations-in-children/

  HHT, also known as Osler-Weber-Rendu syndrome, is the most common cause of multiple cerebral AVMs (42). A meta-analysis found the prevalence of cerebral AVMs in patients with HHT to be 10.4%, with 42.2% of HHT AVM patients having multiple AVMs (43). […] CM-AVM due to RASA1 mutations has been associated with intracranial AVMs and other vascular malformations (44). […] Klippel-Trnaunay syndrome (associated with PIK3CA mutations), Parkes Weber syndrome (often associated with RASA1 mutations), and cerebrofacial arteriovenous metameric syndrome have been associated with intracranial AVMs (41).

• #31 Pulmonary arteriovenous malformations: Epidemiology, etiology, and pathology in adults – UpToDate

  https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults

  PAVMs in the general population have a female preponderance (60 percent) and are typically solitary (90 percent) and unilateral (97 percent). There is a lower lobe predilection, with at least two-thirds of PAVMs occurring in the lower lobes. PAVMs tend to increase slowly in size over time and do not regress spontaneously. […] Most PAVMs (80 to 90 percent) are associated with hereditary hemorrhagic telangiectasia (HHT; also called Osler-Weber-Rendu syndrome), an autosomal dominant genetic disorder characterized by abnormal blood vessel formation. Conversely, approximately 30 to 50 percent of patients with HHT will have PAVMs. In patients with HHT, PAVMs are evenly distributed by sex, more frequently multiple, and more evenly distributed throughout the lungs.

• #32 Epidemiology of Cerebral Arteriovenous Malformations in Children – ISPN Guide

  https://ispn.guide/vascular-disorders-of-the-nervous-system-in-children/cerebral-arteriovenous-malformations-in-children-homepage-2025/epidemiology-of-cerebral-arteriovenous-malformations-in-children/

  HHT, also known as Osler-Weber-Rendu syndrome, is the most common cause of multiple cerebral AVMs (42). A meta-analysis found the prevalence of cerebral AVMs in patients with HHT to be 10.4%, with 42.2% of HHT AVM patients having multiple AVMs (43). […] CM-AVM due to RASA1 mutations has been associated with intracranial AVMs and other vascular malformations (44). […] Klippel-Trnaunay syndrome (associated with PIK3CA mutations), Parkes Weber syndrome (often associated with RASA1 mutations), and cerebrofacial arteriovenous metameric syndrome have been associated with intracranial AVMs (41).

• #33 Epidemiology of Cerebral Arteriovenous Malformations in Children – ISPN Guide

  https://ispn.guide/vascular-disorders-of-the-nervous-system-in-children/cerebral-arteriovenous-malformations-in-children-homepage-2025/epidemiology-of-cerebral-arteriovenous-malformations-in-children/

  HHT, also known as Osler-Weber-Rendu syndrome, is the most common cause of multiple cerebral AVMs (42). A meta-analysis found the prevalence of cerebral AVMs in patients with HHT to be 10.4%, with 42.2% of HHT AVM patients having multiple AVMs (43). […] CM-AVM due to RASA1 mutations has been associated with intracranial AVMs and other vascular malformations (44). […] Klippel-Trnaunay syndrome (associated with PIK3CA mutations), Parkes Weber syndrome (often associated with RASA1 mutations), and cerebrofacial arteriovenous metameric syndrome have been associated with intracranial AVMs (41).

• #34 Arteriovenous malformation – Wikipedia

  https://en.wikipedia.org/wiki/Arteriovenous_malformation

  The estimated detection rate of AVM in the US general population is 1.4/100,000 per year. This is approximately one-fifth to one-seventh the incidence of intracranial aneurysms. An estimated 300,000 Americans have AVMs, of whom 12% (approximately 36,000) will exhibit symptoms of greatly varying severity. […] AVMs can occur in various parts of the body: brain (cerebral AV malformation), spleen, lung, kidney, spinal cord, liver, intercostal space, iris, spermatic cord, extremities arm, shoulder, etc. […] AVMs may occur in isolation or as a part of another disease (for example, Sturge-Weber syndrome or hereditary hemorrhagic telangiectasia).

• #35

  https://insight.jci.org/articles/view/179729

  Brain arteriovenous malformations (bAVMs) affect approximately 10 per 100,000 individuals, causing 1%2% of strokes and one-third of intracerebral hemorrhages in children and young adults. […] Current therapies include microsurgical resection, endovascular embolization, and stereotactic radiosurgery, leading to successful treatment in a majority of cases. […] However, the invasive surgery carries a high risk in cases in which the nidus is large or located in eloquent brain areas. […] A better understanding of the mechanisms underlying the malformation process might help to develop noninvasive therapeutic options. […] Importantly, a recent study identified KRAS gene mutations in the endothelial cells of sporadic cases, showing 28%87% of them harbor somatic mutation. […] The present model reveals pathological processes that lead to postnatal bAVMs and demonstrates the efficacy of therapeutic strategies with CRISPR/CasRx.

• #36 Epidemiology of Arteriovenous Malformations | East Bay Brain & Spine

  https://www.eastbaybrainandspine.com/conditions/vascular/arteriovenous-malformations/epidemiology-arteriovenous-malformations/

  Arteriovenous malformations (AVMs) are relatively rare and occur in less than 1% of the general population. […] The incidence of detection is estimated to be around 1 in every 100,000 people per year. The overall prevalence is believed to be around 18 per 100,000 individuals. […] AVMs can be found at any age, but symptoms usually first appear between the ages of 10 and 40. […] Both sexes are equally affected by AVMs. However, hemorrhage due to AVM rupture is reportedly more common in females. […] The annual risk of hemorrhage in patients with untreated AVMs is estimated to be around 2-4% per year. […] The mortality rate after an AVM rupture is estimated to be around 10-15%, and morbidity (disability) rates are much higher. […] The epidemiology of AVMs underscores the importance of their early detection and appropriate management.

• #37 Complications of Endovascular Treatments for Brain Arteriovenous Malformations: A Nationwide Surveillance | American Journal of Neuroradiology

  http://www.ajnr.org/content/41/4/669

  Patients with complications due to endovascular procedures had worse clinical outcomes 30 days after the procedures than those without complications. […] Complications arising after endovascular treatment of brain arteriovenous malformations are not negligible even though they may play a role in adjunctive therapy, especially in the management of infratentorial brain arteriovenous malformations. […] The annual hemorrhage rate for AVMs is between 2% and 4% per year. […] Despite the fairly large number of patients with bAVMs who are treated with embolization, published data on complications associated with embolization procedures are surprisingly scarce or only based on the experience of a single institution. […] In this study, we retrospectively reviewed a nationwide surveillance to elucidate notable risk factors of procedure-related complications and short-term clinical outcomes after endovascular treatment of bAVMs.

• #38 Arteriovenous Malformations: Practice Essentials, Background, Pathophysiology

  https://emedicine.medscape.com/article/1160167-overview

  In population-based studies, 38-70% of brain AVMs present initially with hemorrhages. The overall risk of intracranial hemorrhage in patients with known AVM is 24% per year. […] Despite the presumed congenital origin of AVMs, the clinical presentation most commonly occurs in young adults. […] A history of subtle learning disorder is elicited in 66% of adults with AVMs. This suggests early effects that are largely subclinical and do not come to medical attention.

• #39 Arteriovenous Malformations: Practice Essentials, Background, Pathophysiology

  https://emedicine.medscape.com/article/1160167-overview

  In population-based studies, 38-70% of brain AVMs present initially with hemorrhages. The overall risk of intracranial hemorrhage in patients with known AVM is 24% per year. […] Despite the presumed congenital origin of AVMs, the clinical presentation most commonly occurs in young adults. […] A history of subtle learning disorder is elicited in 66% of adults with AVMs. This suggests early effects that are largely subclinical and do not come to medical attention.

• #40 Cerebral Arteriovenous Malformation (AVM) | University of Michigan Health

  https://www.uofmhealth.org/conditions-treatments/brain-neurological-conditions/cerebrovascular/cerebrovascular-disease-arteriovenous-malformation

  The University of Michigans Cerebrovascular Program treats approximately 30 brain AVM patients each year. […] Brain AVMs occur in less than 1% of the population. They are more common in males than females. […] Some studies have suggested that patients may suffer a seizure due to an AVM. These patients are at higher risk of hemorrhage. The studies also suggest that in the first year following a spontaneous AVM hemorrhage, the risk of bleeding again may be as high as 6% to 18%. […] A CAT scan of the brain is typically the first step in diagnosing an AVM. […] Treatment depends upon the type of AVM, the symptoms it may be causing, and its location and size.

• #41 Epidemiology of Arteriovenous Malformations | East Bay Brain & Spine

  https://www.eastbaybrainandspine.com/conditions/vascular/arteriovenous-malformations/epidemiology-arteriovenous-malformations/

  Arteriovenous malformations (AVMs) are relatively rare and occur in less than 1% of the general population. […] The incidence of detection is estimated to be around 1 in every 100,000 people per year. The overall prevalence is believed to be around 18 per 100,000 individuals. […] AVMs can be found at any age, but symptoms usually first appear between the ages of 10 and 40. […] Both sexes are equally affected by AVMs. However, hemorrhage due to AVM rupture is reportedly more common in females. […] The annual risk of hemorrhage in patients with untreated AVMs is estimated to be around 2-4% per year. […] The mortality rate after an AVM rupture is estimated to be around 10-15%, and morbidity (disability) rates are much higher. […] The epidemiology of AVMs underscores the importance of their early detection and appropriate management.

• #42 Arteriovenous Malformations: Epidemiology and Clinical Presentation | Neupsy Key

  https://neupsykey.com/arteriovenous-malformations-epidemiology-and-clinical-presentation/

  Arteriovenous malformations (AVMs) of the brain are relatively rare congenital developmental vascular lesions. […] The reported incidence rates of newly diagnosed AVMs have varied in different population-based studies from 0.89 to 1.34 cases per 100,000 personyears. […] The total prevalence of AVMs, including all the asymptomatic lesions, is nevertheless extremely difficult to estimate reliably due to the rarity of the disease. […] Overall annual mortality rates have varied from 0.7% to 2.9% in different study populations, but the mortality rates have usually not been compared with the background population. […] The authors have recently reported that AVM patients have significant excess mortality as compared with matched general population. […] The average annual AVM rupture rate is approximately 2% to 4% in most of these cohorts, but the rate varies highly depending on various risk factors.

• #43 Epidemiology of ruptured brain arteriovenous malformation: a National Cohort Study in Korea in: Journal of Neurosurgery Volume 130 Issue 6 (2018) Journals

  https://thejns.org/view/journals/j-neurosurg/130/6/article-p1965.xml

  Brain arteriovenous malformation (BAVM) is a rare cerebrovascular disease that causes intracranial hemorrhage. Although several reports have demonstrated the epidemiological features of BAVM in Western countries, no epidemiological investigations regarding BAVM have been reported in Korea. The authors aimed to investigate the national epidemiology of ruptured BAVM in a Korean population. […] A total of 8,802,696 person-years of observation were noted. During observation, 308 patients were diagnosed with a ruptured BAVM. The crude incidence of ruptured BAVM was 3.5 per 100,000 person-years. […] The standardized incidence of ruptured BAVMs was 3.6 per 100,000 person-years in Korea. Ruptured BAVMs resulted in high mortality and disability rates.

• #44 Complications of Endovascular Treatments for Brain Arteriovenous Malformations: A Nationwide Surveillance | American Journal of Neuroradiology

  http://www.ajnr.org/content/41/4/669

  The 30-day morbidity and mortality rates were 291 (27.9%) and 8 (0.8%) of 1042 procedures, respectively. […] Endovascular procedures with complications were significantly associated with worse outcome compared with procedures without complications. […] We observed that complications of endovascular treatment may result in worse outcomes in patients with bAVMs. Thus, interventionalists should be aware of potential complications, especially in the management of infratentorial AVMs.

• #45 Pulmonary arteriovenous malformations: Epidemiology, etiology, and pathology in adults – UpToDate

  https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults

  PAVMs in the general population have a female preponderance (60 percent) and are typically solitary (90 percent) and unilateral (97 percent). There is a lower lobe predilection, with at least two-thirds of PAVMs occurring in the lower lobes. PAVMs tend to increase slowly in size over time and do not regress spontaneously. […] Most PAVMs (80 to 90 percent) are associated with hereditary hemorrhagic telangiectasia (HHT; also called Osler-Weber-Rendu syndrome), an autosomal dominant genetic disorder characterized by abnormal blood vessel formation. Conversely, approximately 30 to 50 percent of patients with HHT will have PAVMs. In patients with HHT, PAVMs are evenly distributed by sex, more frequently multiple, and more evenly distributed throughout the lungs.

• #46 Arteriovenous Malformation | AdventHealth Neuroscience Institute

  https://www.adventhealthneuroinstitute.com/arteriovenous-malformation

  Brain AVMs are highly rare and occur in less than 1% of the general population. […] Over the course of a lifetime, AVMs will grow and change along with a persons body. […] Theyre more common in men, and the risk of developing AVMs may be genetic. […] The biggest concern for people with brain AVMs is uncontrolled bleeding, or a hemorrhage. Less than 4% of AVMs hemorrhage, but when it happens, the effects can be severe and even fatal. […] About 1% of people with AVMs die from the condition. […] Many people only find out about an AVM when it bleeds, which can cause a stroke. […] If you suspect you have an AVM, contact your doctor, even if the symptoms are not obvious. […] Testing may need to be repeated to monitor changes in the size of the AVM, bleeding or new lesions. […] When an AVM is found, depending on its type, location and size, your doctor may recommend treatment.

• #47 Management of Pediatric Intracranial Arteriovenous Malformations

  https://www.jkns.or.kr/journal/view.php?number=7699

  Most centers endorse an aggressive approach toward the treatment of AVMs in the pediatric population, due to devastating impact of bleeding and cognizance that the long lifespan of a child confers a greater cumulative risk over time. Fundamental to any treatment is the acknowledgement that the primary endpoint of an intervention is total shutdown or removal of the AVM, as anything less than total cure means that the lesion can recanalize in the future and – with this return of flow – still kill the patient by rupture. […] Overall, close to 95% of surgical cases demonstrate long-term cure, although recurrence can happen even years later and one of the most common permanent deficits is a visual field cut, reported in about one out of seven cases. Comparing the efficacy of radiation for similar grade AVMs, roughly 75% long-term control is average. A growing area of concern is the appreciation that children treated for AVMs can experience recurrence/regrowth, even years later, with as many as one in 10 cases affected and recurrence estimated at 1% after 5 years for all comers. This emerging body of evidence has highlighted the value of ensuring complete removal at surgery, including the use of intra/peri-operative DSA (which has revealed up to 1/5th of cases may have unsuspected residual at time of surgery), as well as continued radiographic follow-up for the long term postoperatively, especially for AVMs with indistinct margins and those that presented with hemorrhage.

• #48 Management of Pediatric Intracranial Arteriovenous Malformations

  https://www.jkns.or.kr/journal/view.php?number=7699

  Most centers endorse an aggressive approach toward the treatment of AVMs in the pediatric population, due to devastating impact of bleeding and cognizance that the long lifespan of a child confers a greater cumulative risk over time. Fundamental to any treatment is the acknowledgement that the primary endpoint of an intervention is total shutdown or removal of the AVM, as anything less than total cure means that the lesion can recanalize in the future and – with this return of flow – still kill the patient by rupture. […] Overall, close to 95% of surgical cases demonstrate long-term cure, although recurrence can happen even years later and one of the most common permanent deficits is a visual field cut, reported in about one out of seven cases. Comparing the efficacy of radiation for similar grade AVMs, roughly 75% long-term control is average. A growing area of concern is the appreciation that children treated for AVMs can experience recurrence/regrowth, even years later, with as many as one in 10 cases affected and recurrence estimated at 1% after 5 years for all comers. This emerging body of evidence has highlighted the value of ensuring complete removal at surgery, including the use of intra/peri-operative DSA (which has revealed up to 1/5th of cases may have unsuspected residual at time of surgery), as well as continued radiographic follow-up for the long term postoperatively, especially for AVMs with indistinct margins and those that presented with hemorrhage.

• #49 Brain Arteriovenous Malformation (AVM) – Diagnosis and TreatmentSecond Opinion IconGroup 49Group 49

  https://www.barrowneuro.org/condition/arteriovenous-malformation-avm/

  An AVM is very rare and affects less than one percent of the population, or about 10 per 100,000 people. […] An estimated 300,000 Americans are affected by arteriovenous malformations of the brain and spinal cord (neurological AVMs), but only about 12 percent of the affected population will have symptoms. […] Arteriovenous malformations are equally common among men and women of all races and ethnicities. They are believed to be congenital (existing at birth), but they can enlarge over time and cause symptoms at any age. […] Most arteriovenous malformations are detected through diagnostic imaging, such as a CT or MRI scan. Angiography, an imaging technique that involves the injection of a special dye, may be used to get a better look at the AVM. […] Because most people with AVMs experience few symptoms, they are often discovered during treatment for an unrelated disorder.

• #50 Arteriovenous malformations: epidemiology and clinical presentation – PubMed

  https://pubmed.ncbi.nlm.nih.gov/22107853/

  Arteriovenous malformations (AVMs) of the brain are relatively rare congenital developmental vascular lesions. […] The incidence of asymptomatic AVMs is increasing due to widespread availability of noninvasive imaging methods. […] Since the most severe complication of an AVM is hemorrhagic stroke, most epidemiologic studies have concentrated on the hemorrhage risk and its risk factors. […] In this article, the authors discuss the epidemiology, presenting symptoms, and hemorrhage risk associated with brain AVMs.

• #51 Brain Arteriovenous Malformations | Radiology Key

  https://radiologykey.com/brain-arteriovenous-malformations-2/

  Brain arteriovenous malformations (AVMs) are rare lesions, with an estimated detection rate of 1 to 1.3 per 100,000 person-years over several population-based studies. […] According to the literature, untreated AVMs carry a 2% to 4% annual risk of hemorrhage; however, in a single prospective randomized trial, treatment of unruptured AVMs was associated with an even higher rate of periprocedural complications. […] Long-term follow-up imaging from AVMs generally is appropriate, but the schedule depends on the type of management and patient characteristics. […] The purpose of imaging an AVM is first to identify features that indicate an elevated risk of hemorrhage or other morbidity, such as perinidal hypoxemia, and second to inform the choice of treatment or observation that provides the best balance of risk and benefit to the individual patient. Longitudinal imaging surveillance, either with conservative management or after treatment, enables monitoring for resolution of the AVM or the development of adverse findings that may necessitate a change in management.

• #52 Arteriovenous Malformation | AdventHealth Neuroscience Institute

  https://www.adventhealthneuroinstitute.com/arteriovenous-malformation

  Brain AVMs are highly rare and occur in less than 1% of the general population. […] Over the course of a lifetime, AVMs will grow and change along with a persons body. […] Theyre more common in men, and the risk of developing AVMs may be genetic. […] The biggest concern for people with brain AVMs is uncontrolled bleeding, or a hemorrhage. Less than 4% of AVMs hemorrhage, but when it happens, the effects can be severe and even fatal. […] About 1% of people with AVMs die from the condition. […] Many people only find out about an AVM when it bleeds, which can cause a stroke. […] If you suspect you have an AVM, contact your doctor, even if the symptoms are not obvious. […] Testing may need to be repeated to monitor changes in the size of the AVM, bleeding or new lesions. […] When an AVM is found, depending on its type, location and size, your doctor may recommend treatment.

• #53 Cerebral Arteriovenous Malformation AVM

  https://www.rch.org.au/kidsinfo/fact_sheets/Cerebral_Arteriovenous_Malformation_AVM/

  AVMs in the brain occur in approximately 1 in 3,300 people and bleeding from an AVM most often occurs between 10 and 30 years of age. […] Your child will have regular surveillance imaging and follow-up appointments with their treating team. […] Yes it is possible that after treatment for a cerebral AVM there may be recurrence of a tiny cluster of AVM vessels in the area treated. This is why your treating team of doctors will arrange follow up imaging (with MRI or angiogram) for several years after the initial treatment to check for this possibility.

• #54 Cerebral Arteriovenous Malformation AVM

  https://www.rch.org.au/kidsinfo/fact_sheets/Cerebral_Arteriovenous_Malformation_AVM/

  AVMs in the brain occur in approximately 1 in 3,300 people and bleeding from an AVM most often occurs between 10 and 30 years of age. […] Your child will have regular surveillance imaging and follow-up appointments with their treating team. […] Yes it is possible that after treatment for a cerebral AVM there may be recurrence of a tiny cluster of AVM vessels in the area treated. This is why your treating team of doctors will arrange follow up imaging (with MRI or angiogram) for several years after the initial treatment to check for this possibility.

• #55 Successful Endovascular Treatment of a Ruptured Giant Lumbar Arteriovenous Malformation

  https://www.vsijournal.org/journal/view.html?pn=search&uid=1136&vmd=Full

  Arteriovenous malformations (AVMs) are rare congenital vascular anomalies where rupture can be fatal. […] However, follow-up CTA showed residual contrast enhancement in the AVM and further surveillance is required. […] Vascular specialists usually recommend treatment of symptomatic AVMs, however, available evidence is scarce and currently no treatment guidelines exist. […] Due to the reticular vascular structure of AVMs with increased risk of neovascularization after local thrombosis, surveillance is necessary even in cases without any residual AVM perfusion. […] In this case, we will continue surveillance despite the current steady-state situation. […] In conclusion, VMs require interdisciplinary and individually tailored management.

• #56 Successful Endovascular Treatment of a Ruptured Giant Lumbar Arteriovenous Malformation

  https://www.vsijournal.org/journal/view.html?pn=search&uid=1136&vmd=Full

  Arteriovenous malformations (AVMs) are rare congenital vascular anomalies where rupture can be fatal. […] However, follow-up CTA showed residual contrast enhancement in the AVM and further surveillance is required. […] Vascular specialists usually recommend treatment of symptomatic AVMs, however, available evidence is scarce and currently no treatment guidelines exist. […] Due to the reticular vascular structure of AVMs with increased risk of neovascularization after local thrombosis, surveillance is necessary even in cases without any residual AVM perfusion. […] In this case, we will continue surveillance despite the current steady-state situation. […] In conclusion, VMs require interdisciplinary and individually tailored management.

• #57 National reduction in cerebral arteriovenous malformation treatment correlated with increased rupture incidence | Journal of NeuroInterventional Surgery

  https://jnis.bmj.com/content/15/8/735

  A total of 90296 AVM admissions were identified between 2010 and 2017. […] Higher average annual AVM rupture incidence was observed in the post-2014 period (14.7 vs 18.6%, p0.0001). […] A significant decrease in unruptured AVM interventions was observed post-2014 (28.1% to 22.3%, p0.0001). […] The segmented average annual percent change for annual interventions was 0.63% (95% CI 1.1% to 0.2%, p=0.0048) before 2014 and 3.71% (95% CI 7.5% to 0.06%, p=0.0596) after 2014. […] A significant national decrease in unruptured AVM interventions was observed in the years following 2014. From 2003 to 2017, decreases in unruptured AVM interventions have been followed by a correlated lagged increase in the incidence of ruptured AVMs.

• #58 National reduction in cerebral arteriovenous malformation treatment correlated with increased rupture incidence | Journal of NeuroInterventional Surgery

  https://jnis.bmj.com/content/15/8/735

  A total of 90296 AVM admissions were identified between 2010 and 2017. […] Higher average annual AVM rupture incidence was observed in the post-2014 period (14.7 vs 18.6%, p0.0001). […] A significant decrease in unruptured AVM interventions was observed post-2014 (28.1% to 22.3%, p0.0001). […] The segmented average annual percent change for annual interventions was 0.63% (95% CI 1.1% to 0.2%, p=0.0048) before 2014 and 3.71% (95% CI 7.5% to 0.06%, p=0.0596) after 2014. […] A significant national decrease in unruptured AVM interventions was observed in the years following 2014. From 2003 to 2017, decreases in unruptured AVM interventions have been followed by a correlated lagged increase in the incidence of ruptured AVMs.

• #59 National reduction in cerebral arteriovenous malformation treatment correlated with increased rupture incidence | Journal of NeuroInterventional Surgery

  https://jnis.bmj.com/content/15/8/735

  A total of 90296 AVM admissions were identified between 2010 and 2017. […] Higher average annual AVM rupture incidence was observed in the post-2014 period (14.7 vs 18.6%, p0.0001). […] A significant decrease in unruptured AVM interventions was observed post-2014 (28.1% to 22.3%, p0.0001). […] The segmented average annual percent change for annual interventions was 0.63% (95% CI 1.1% to 0.2%, p=0.0048) before 2014 and 3.71% (95% CI 7.5% to 0.06%, p=0.0596) after 2014. […] A significant national decrease in unruptured AVM interventions was observed in the years following 2014. From 2003 to 2017, decreases in unruptured AVM interventions have been followed by a correlated lagged increase in the incidence of ruptured AVMs.

• #60 National reduction in cerebral arteriovenous malformation treatment correlated with increased rupture incidence | Journal of NeuroInterventional Surgery

  https://jnis.bmj.com/content/15/8/735

  A total of 90296 AVM admissions were identified between 2010 and 2017. […] Higher average annual AVM rupture incidence was observed in the post-2014 period (14.7 vs 18.6%, p0.0001). […] A significant decrease in unruptured AVM interventions was observed post-2014 (28.1% to 22.3%, p0.0001). […] The segmented average annual percent change for annual interventions was 0.63% (95% CI 1.1% to 0.2%, p=0.0048) before 2014 and 3.71% (95% CI 7.5% to 0.06%, p=0.0596) after 2014. […] A significant national decrease in unruptured AVM interventions was observed in the years following 2014. From 2003 to 2017, decreases in unruptured AVM interventions have been followed by a correlated lagged increase in the incidence of ruptured AVMs.

• #61

  https://scholars.duke.edu/publication/731190

  Spinal arteriovenous malformations (AVMs) are rare and understudied vascular lesions that cause neurological insult by mass effect, venous obstruction, and vascular steal. […] Trends in procedural management, hospital course, and epidemiology of spinal AVMs are investigated. […] Annually, an average of 300 patients presented with spinal AVMs requiring hospital treatment. […] The average length of hospital stay for this treatment has declined from more than 9 days in 1995 to 6 days in 2006. […] However, the average cost of a hospital stay has increased from $30,000 to nearly $70,000. […] Whereas one-half of spinal AVMs were treated operatively in 1995, one-third were managed operatively in 2006. […] Spinal AVMs are being increasingly treated by endovascular, radiosurgical, or combined means.

• #62

  https://scholars.duke.edu/publication/731190

  Spinal arteriovenous malformations (AVMs) are rare and understudied vascular lesions that cause neurological insult by mass effect, venous obstruction, and vascular steal. […] Trends in procedural management, hospital course, and epidemiology of spinal AVMs are investigated. […] Annually, an average of 300 patients presented with spinal AVMs requiring hospital treatment. […] The average length of hospital stay for this treatment has declined from more than 9 days in 1995 to 6 days in 2006. […] However, the average cost of a hospital stay has increased from $30,000 to nearly $70,000. […] Whereas one-half of spinal AVMs were treated operatively in 1995, one-third were managed operatively in 2006. […] Spinal AVMs are being increasingly treated by endovascular, radiosurgical, or combined means.

• #63

  https://scholars.duke.edu/publication/731190

  Spinal arteriovenous malformations (AVMs) are rare and understudied vascular lesions that cause neurological insult by mass effect, venous obstruction, and vascular steal. […] Trends in procedural management, hospital course, and epidemiology of spinal AVMs are investigated. […] Annually, an average of 300 patients presented with spinal AVMs requiring hospital treatment. […] The average length of hospital stay for this treatment has declined from more than 9 days in 1995 to 6 days in 2006. […] However, the average cost of a hospital stay has increased from $30,000 to nearly $70,000. […] Whereas one-half of spinal AVMs were treated operatively in 1995, one-third were managed operatively in 2006. […] Spinal AVMs are being increasingly treated by endovascular, radiosurgical, or combined means.

• #64

  https://scholars.duke.edu/publication/731190

  Spinal arteriovenous malformations (AVMs) are rare and understudied vascular lesions that cause neurological insult by mass effect, venous obstruction, and vascular steal. […] Trends in procedural management, hospital course, and epidemiology of spinal AVMs are investigated. […] Annually, an average of 300 patients presented with spinal AVMs requiring hospital treatment. […] The average length of hospital stay for this treatment has declined from more than 9 days in 1995 to 6 days in 2006. […] However, the average cost of a hospital stay has increased from $30,000 to nearly $70,000. […] Whereas one-half of spinal AVMs were treated operatively in 1995, one-third were managed operatively in 2006. […] Spinal AVMs are being increasingly treated by endovascular, radiosurgical, or combined means.

• #65 Cerebral Arteriovenous Malformation (AVM) | University of Michigan Health

  https://www.uofmhealth.org/conditions-treatments/brain-neurological-conditions/cerebrovascular/cerebrovascular-disease-arteriovenous-malformation

  The University of Michigans Cerebrovascular Program treats approximately 30 brain AVM patients each year. […] Brain AVMs occur in less than 1% of the population. They are more common in males than females. […] Some studies have suggested that patients may suffer a seizure due to an AVM. These patients are at higher risk of hemorrhage. The studies also suggest that in the first year following a spontaneous AVM hemorrhage, the risk of bleeding again may be as high as 6% to 18%. […] A CAT scan of the brain is typically the first step in diagnosing an AVM. […] Treatment depends upon the type of AVM, the symptoms it may be causing, and its location and size.

• #66 Management of Pediatric Intracranial Arteriovenous Malformations

  https://www.jkns.or.kr/journal/view.php?number=7699

  Pediatric intracranial arteriovenous malformations (AVMs) are challenging lesions managed by pediatric neurosurgeons. The high risk of hemorrhage and neurologic injury is compounded by the unique anatomy of each malformation that requires individualizing treatment options. This article reviews the current status of pediatric AVM epidemiology, pathophysiology and clinical care, with a specific focus on the rationale and methodology of surgical resection. […] AVM is the most common symptomatic intracranial vascular abnormality. In a large autopsy series the overall frequency of detection for AVMs was 1.4% (46 among 3200 brain tumor cases). In another report, the annual incidence of symptomatic AVMs was 1.1 per 100000 and about one-in-five AVMs will present in children. CNS AVMs are present in about 1/5000 children with no sex preference and represent about one sixth of AVMs in the general population.

• #67 Management of Pediatric Intracranial Arteriovenous Malformations

  https://www.jkns.or.kr/journal/view.php?number=7699

  Pediatric intracranial arteriovenous malformations (AVMs) are challenging lesions managed by pediatric neurosurgeons. The high risk of hemorrhage and neurologic injury is compounded by the unique anatomy of each malformation that requires individualizing treatment options. This article reviews the current status of pediatric AVM epidemiology, pathophysiology and clinical care, with a specific focus on the rationale and methodology of surgical resection. […] AVM is the most common symptomatic intracranial vascular abnormality. In a large autopsy series the overall frequency of detection for AVMs was 1.4% (46 among 3200 brain tumor cases). In another report, the annual incidence of symptomatic AVMs was 1.1 per 100000 and about one-in-five AVMs will present in children. CNS AVMs are present in about 1/5000 children with no sex preference and represent about one sixth of AVMs in the general population.

• #68 Management of Pediatric Intracranial Arteriovenous Malformations

  https://www.jkns.or.kr/journal/view.php?number=7699

  Pediatric intracranial arteriovenous malformations (AVMs) are challenging lesions managed by pediatric neurosurgeons. The high risk of hemorrhage and neurologic injury is compounded by the unique anatomy of each malformation that requires individualizing treatment options. This article reviews the current status of pediatric AVM epidemiology, pathophysiology and clinical care, with a specific focus on the rationale and methodology of surgical resection. […] AVM is the most common symptomatic intracranial vascular abnormality. In a large autopsy series the overall frequency of detection for AVMs was 1.4% (46 among 3200 brain tumor cases). In another report, the annual incidence of symptomatic AVMs was 1.1 per 100000 and about one-in-five AVMs will present in children. CNS AVMs are present in about 1/5000 children with no sex preference and represent about one sixth of AVMs in the general population.

• #69 Management of Pediatric Intracranial Arteriovenous Malformations

  https://www.jkns.or.kr/journal/view.php?number=7699

  Most centers endorse an aggressive approach toward the treatment of AVMs in the pediatric population, due to devastating impact of bleeding and cognizance that the long lifespan of a child confers a greater cumulative risk over time. Fundamental to any treatment is the acknowledgement that the primary endpoint of an intervention is total shutdown or removal of the AVM, as anything less than total cure means that the lesion can recanalize in the future and – with this return of flow – still kill the patient by rupture. […] Overall, close to 95% of surgical cases demonstrate long-term cure, although recurrence can happen even years later and one of the most common permanent deficits is a visual field cut, reported in about one out of seven cases. Comparing the efficacy of radiation for similar grade AVMs, roughly 75% long-term control is average. A growing area of concern is the appreciation that children treated for AVMs can experience recurrence/regrowth, even years later, with as many as one in 10 cases affected and recurrence estimated at 1% after 5 years for all comers. This emerging body of evidence has highlighted the value of ensuring complete removal at surgery, including the use of intra/peri-operative DSA (which has revealed up to 1/5th of cases may have unsuspected residual at time of surgery), as well as continued radiographic follow-up for the long term postoperatively, especially for AVMs with indistinct margins and those that presented with hemorrhage.

• #70 Uterine arteriovenous malformation | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/uterine-arteriovenous-malformation?lang=us

  Uterine arteriovenous malformations are rare and can either be congenital or acquired. Acquired arteriovenous malformations are more common and are associated with conditions such as multiple pregnancies, miscarriage, and previous surgery (dilation and curettage, termination of pregnancy, cesarean section). […] Uterine arteriovenous malformations are rare and can either be congenital or acquired. Acquired arteriovenous malformations are more common and are associated with conditions such as multiple pregnancies, miscarriage, and previous surgery (dilation and curettage, termination of pregnancy, cesarean section).

• #71 Arteriovenous Malformations (AVM) | Living With Paralysis

  https://www.christopherreeve.org/todays-care/living-with-paralysis/health/causes-of-paralysis/arteriovenous-malformations/

  AVMs can occur in any part of the body. […] Occurrence of sAVM is less than 3% of the population which makes AVM a very rare condition. […] The average age for sAVM diagnosis is about 30-45 years but can occur at any time in the lifespan. […] Research of AVMs is very active. Researchers are looking at the source of AVMs. […] Another line of research is to determine if and when AVMs should be surgically treated. […] Long term effects of sAVMs are being studied extensively through the research into spinal cord injury in prevention and reduction of secondary conditions.

• #72 Arteriovenous Malformations (AVM) | Living With Paralysis

  https://www.christopherreeve.org/todays-care/living-with-paralysis/health/causes-of-paralysis/arteriovenous-malformations/

  AVMs can occur in any part of the body. […] Occurrence of sAVM is less than 3% of the population which makes AVM a very rare condition. […] The average age for sAVM diagnosis is about 30-45 years but can occur at any time in the lifespan. […] Research of AVMs is very active. Researchers are looking at the source of AVMs. […] Another line of research is to determine if and when AVMs should be surgically treated. […] Long term effects of sAVMs are being studied extensively through the research into spinal cord injury in prevention and reduction of secondary conditions.

• #73 Arteriovenous Malformations (AVM) | Living With Paralysis

  https://www.christopherreeve.org/todays-care/living-with-paralysis/health/causes-of-paralysis/arteriovenous-malformations/

  AVMs can occur in any part of the body. […] Occurrence of sAVM is less than 3% of the population which makes AVM a very rare condition. […] The average age for sAVM diagnosis is about 30-45 years but can occur at any time in the lifespan. […] Research of AVMs is very active. Researchers are looking at the source of AVMs. […] Another line of research is to determine if and when AVMs should be surgically treated. […] Long term effects of sAVMs are being studied extensively through the research into spinal cord injury in prevention and reduction of secondary conditions.

• #74

  https://insight.jci.org/articles/view/179729

  The present study established a bAVM model that developed vascular tangles with nidus structure during the early postnatal period. […] This enabled us to examine the postnatal process of malformation, showing a multitude of changes in gene expressions and activations in endothelial and surrounding cells. […] The present model will offer an ideal preclinical model in this context. […] The present study shows a proof of concept regarding the effect of CRISPR/CasRx viral delivery, which will contribute to develop novel therapeutic approaches.

• #75

  https://insight.jci.org/articles/view/179729

  The present study established a bAVM model that developed vascular tangles with nidus structure during the early postnatal period. […] This enabled us to examine the postnatal process of malformation, showing a multitude of changes in gene expressions and activations in endothelial and surrounding cells. […] The present model will offer an ideal preclinical model in this context. […] The present study shows a proof of concept regarding the effect of CRISPR/CasRx viral delivery, which will contribute to develop novel therapeutic approaches.

• #76

  https://insight.jci.org/articles/view/179729

  Brain arteriovenous malformations (bAVMs) affect approximately 10 per 100,000 individuals, causing 1%2% of strokes and one-third of intracerebral hemorrhages in children and young adults. […] Current therapies include microsurgical resection, endovascular embolization, and stereotactic radiosurgery, leading to successful treatment in a majority of cases. […] However, the invasive surgery carries a high risk in cases in which the nidus is large or located in eloquent brain areas. […] A better understanding of the mechanisms underlying the malformation process might help to develop noninvasive therapeutic options. […] Importantly, a recent study identified KRAS gene mutations in the endothelial cells of sporadic cases, showing 28%87% of them harbor somatic mutation. […] The present model reveals pathological processes that lead to postnatal bAVMs and demonstrates the efficacy of therapeutic strategies with CRISPR/CasRx.

• #77 Epidemiology of Vascular Malformations | Oncohema Key

  https://oncohemakey.com/epidemiology-of-vascular-malformations/

  Epidemiological data on congenital vascular malformations (CVM) has been confusing due to various definitions and classifications. […] Despite advancements in the understanding of CVMs, substantial confusion remains regarding their epidemiologic data. […] The overall incidence of CVM has been reported as 1.08%, with variability in reporting methods due to differences in terminology and diagnostic criteria. […] The prevalence of deep venous anomalies among vascular malformations has been confirmed in various studies, indicating that venous malformations are the most common type of CVM. […] The incidence of arteriovenous malformations (AVMs) is relatively rare compared to other types of vascular malformations.

• #78

  https://journals.lww.com/neurosurgery/fulltext/2000/08000/the_epidemiology_of_brain_arteriovenous.23.aspx

  Common estimates of the prevalence rate for pial arteriovenous malformations (AVMs) of the brain vary widely, and their accuracy is questionable. Our objective was to critically review the original sources from which these rates were derived and to establish best estimates for both the incidence and prevalence of the disease. […] Many of the prevalence estimates (500600/100,000 population) were based on autopsy data, a source that is inherently biased. Other estimates (140/100,000 population) originated from an inappropriate analysis of data from the Cooperative Study. The most reliable information comes from a population-based study of Olmsted County, MN, but prevalence data specific to AVMs was not found in that study. […] The estimates for AVM prevalence that are published in the medical literature are unfounded. Because of the rarity of the disease and the existence of asymptomatic patients, establishing a true prevalence rate is not feasible. Owing to variation in the detection rate of asymptomatic AVMs, the most reliable estimate for the occurrence of the disease is the detection rate for symptomatic lesions: 0.94 per 100,000 person-years (95% confidence interval, 0.571.30/100,000 person-years). This figure is derived from a single population-based study, but it is supported by a reanalysis of other data sources. The prevalence of detected, active (at risk) AVM disease is unknown, but it can be inferred from incidence data to be lower than 10.3 per 100,000 population.

• #79

  https://journals.lww.com/neurosurgery/fulltext/2000/08000/the_epidemiology_of_brain_arteriovenous.23.aspx

  Common estimates of the prevalence rate for pial arteriovenous malformations (AVMs) of the brain vary widely, and their accuracy is questionable. Our objective was to critically review the original sources from which these rates were derived and to establish best estimates for both the incidence and prevalence of the disease. […] Many of the prevalence estimates (500600/100,000 population) were based on autopsy data, a source that is inherently biased. Other estimates (140/100,000 population) originated from an inappropriate analysis of data from the Cooperative Study. The most reliable information comes from a population-based study of Olmsted County, MN, but prevalence data specific to AVMs was not found in that study. […] The estimates for AVM prevalence that are published in the medical literature are unfounded. Because of the rarity of the disease and the existence of asymptomatic patients, establishing a true prevalence rate is not feasible. Owing to variation in the detection rate of asymptomatic AVMs, the most reliable estimate for the occurrence of the disease is the detection rate for symptomatic lesions: 0.94 per 100,000 person-years (95% confidence interval, 0.571.30/100,000 person-years). This figure is derived from a single population-based study, but it is supported by a reanalysis of other data sources. The prevalence of detected, active (at risk) AVM disease is unknown, but it can be inferred from incidence data to be lower than 10.3 per 100,000 population.

• #80 A Review of the Current State and Future Directions for Management of Scalp and Facial Vascular Malformations

  https://www.jkns.or.kr/journal/view.php?number=7713

  Vascular malformations are structural abnormalities that are thought to result from errors in vasculogenesis and angiogenesis during embryogenesis. […] Arteriovenous malformations (AVMs) involve a tangle of abnormal blood vessels connecting arteries and veins. […] Recent studies suggest that 10 in 10000 Americans have a symptomatic AVM, although the actual prevalence rate is much higher due to clinically undetected AVMs. […] Only 12% of AVMs are expected to become symptomatic. […] There is no gender disparity in incidence or clinical course of AVMs. […] Many pathways have been suggested for AVM formation, but their role in extracranial AVM formation has not been thoroughly investigated. […] The central concern of AVM management is whether it is riskier to leave the AVM untreated or to intervene.

Zobacz więcej